Uncategorized
TEPEZZA® (teprotumumab-trbw) Data from the Phase 2 Clinical Trial Evaluate Longer-Term Responses in People Living with Thyroid Eye Disease (TED)
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced TEPEZZA® data from the Phase 2 trial, which evaluate longer-term responses in people with Thyroid Eye Disease (TED).